Medical Probiotics Market Size, Share & Trends Analysis Report By Ingredient Type (Bacteria (Lactobacilli, Bifidobacterium, Streptococcus, and Bacillus), Yeast, Spore Formers, and Others), By Application (Probiotic Food & Beverages, Probiotic Dietary Supplements, Probiotics for Women’s Health, Infant Formula, and Others), By Distribution Channel, By Region, And By Segment Forecasts, 2023-2031

Report Id: 2240 Pages: 179 Last Updated: 29 October 2024 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Medical Probiotics Market-

Medical Probiotics Market By Ingredient Type

  • Bacteria
    • Lactobacilli
    • Bifidobacterium
    • Streptococcus
    • Bacillus
  • Yeast
  • Spore Formers
  • Others

Medical Probiotics Market Seg

Medical Probiotics Market By Application                          

  • Probiotic Food & Beverages
    • Dairy Products
    • Non-dairy Beverages
    • Cereals
    • Baked Goods
    • Fermented Meat Products
  • Probiotic Dietary Supplements
  • Probiotics for Women's Health
  • Infant Formula
  • Others

Medical Probiotics Market By Distribution Channel

  • Hypermarkets/Supermarkets
  • Pharmacies/Drugstores
  • Specialty Stores
  • Online Sales

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Medical Probiotics Market Snapshot

Chapter 4. Global Medical Probiotics Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Ingredient Type Estimates & Trend Analysis

5.1. By Ingredient Type, & Market Share, 2020 & 2031

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Ingredient Type:

5.2.1. Bacteria

5.2.1.1. Lactobacilli

5.2.1.2. Bifidobacterium

5.2.1.3. Streptococcus

5.2.1.4. Bacillus

5.2.2. Yeast

5.2.3. Spore Formers

5.2.4. Others

Chapter 6. Market Segmentation 2: By Distribution Channel Estimates & Trend Analysis

6.1. By Distribution Channel & Market Share, 2020 & 2031

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Distribution Channel:

6.2.1. Hypermarkets/Supermarkets

6.2.2. Pharmacies/Drugstores

6.2.3. Specialty Stores

6.2.4. Online Sales

Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis

7.1. By Application & Market Share, 2020 & 2031

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Application:

7.2.1. Probiotic Food & Beverages

7.2.1.1. Dairy Products

7.2.1.2. Non-dairy Beverages

7.2.1.3. Cereals

7.2.1.4. Baked Goods

7.2.1.5. Fermented Meat Products

7.2.2. Probiotic Dietary Supplements

7.2.3. Probiotics for Women’s Health

7.2.4. Infant Formula

7.2.5. Others

Chapter 8. Medical Probiotics Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Medical Probiotics Market revenue (US$ Million) estimates and forecasts By Ingredient Type, 2019-2031

8.1.2. North America Medical Probiotics Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2019-2031

8.1.3. North America Medical Probiotics Market revenue (US$ Million) estimates and forecasts By Application, 2019-2031

8.1.4. North America Medical Probiotics Market revenue (US$ Million) estimates and forecasts by country, 2019-2031

8.2. Europe

8.2.1. Europe Medical Probiotics Market revenue (US$ Million) By Ingredient Type, 2019-2031

8.2.2. Europe Medical Probiotics Market revenue (US$ Million) By Distribution Channel, 2019-2031

8.2.3. Europe Medical Probiotics Market revenue (US$ Million) By Application, 2019-2031

8.2.4. Europe Medical Probiotics Market revenue (US$ Million) by country, 2019-2031

8.3. Asia Pacific

8.3.1. Asia Pacific Medical Probiotics Market revenue (US$ Million) By Ingredient Type, 2019-2031

8.3.2. Asia Pacific Medical Probiotics Market revenue (US$ Million) By Distribution Channel, 2019-2031

8.3.3. Asia Pacific Medical Probiotics Market revenue (US$ Million) By Application, 2019-2031

8.3.4. Asia Pacific Medical Probiotics Market revenue (US$ Million) by country, 2019-2031

8.4. Latin America

8.4.1. Latin America Medical Probiotics Market revenue (US$ Million) By Ingredient Type, (US$ Million) 2019-2031

8.4.2. Latin America Medical Probiotics Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031

8.4.3. Latin America Medical Probiotics Market revenue (US$ Million) By Application, (US$ Million) 2019-2031

8.4.4. Latin America Medical Probiotics Market revenue (US$ Million) by country, 2019-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Medical Probiotics Market revenue (US$ Million) By Ingredient Type, (US$ Million) 2019-2031

8.5.2. Middle East & Africa Medical Probiotics Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2019-2031

8.5.3. Middle East & Africa Medical Probiotics Market revenue (US$ Million) By Application, (US$ Million) 2019-2031

8.5.4. Middle East & Africa Medical Probiotics Market revenue (US$ Million) by country, 2019-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Probi AB,

9.2.2. Abbott,

9.2.3. Lonza, Chr.

9.2.4. Hansen Holding A/S,

9.2.5. Danone S.A.,

9.2.6. Yakult Honsha Co., Ltd.,

9.2.7. Nestle S.A.,

9.2.8. DowDuPont Inc.,

9.2.9. Kerry Group plc.,

9.2.10. BioGaia AB, DSM,

9.2.11. Sun Genomics,

9.2.12. Evonik,

9.2.13. Probiotics International Limited (Protexin),

9.2.14. UAS Laboratories LLC,.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
5978
Security Code field cannot be blank!

Frequently Asked Questions

Medical Probiotics Market Size is valued at USD 39.32 Bn in 2022 and is predicted to reach USD 64.13 Bn by the year 2031

Medical Probiotics Market expected to grow at a 5.76% CAGR during the forecast period for 2023-2031.

Winclove Probiotics, Sacco System, General Mills Inc., ADM, Unique Biotech Ltd, Lifeway Foods, Inc., Suja Life, Llc, Biohm Health, Others

Ingredient Type, Application and Distribution Channel are the key segments of the Medical Probiotics Market.

North American region is leading the Medical Probiotics Market.
Get Sample Report Enquiry Before Buying